Jinendra Qualipharm Private Limited
About Jinendra Qualipharm Private Limited
Data last updated:
Jinendra Qualipharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 October 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC196480. Its GSTIN is 27AACCJ2407R1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.3 Lakh. It is led by directors including Ajit Jain and Anju Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.3 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹16.89 Cr (net margin 69.5%) and EBITDA of ₹23 Cr (EBITDA margin 94.7%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 219% over five years.
The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹55 Lakh; the latest was in March 2022. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Sunberg Life Sciences Private Limited with revenue of ₹24.43 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No. B – 4001 40th Floor B Wing Lodha Evoq Plot No.Block – C (C1 – Zone) Wadala Truc, K Terminal, Mumbai, Maharashtra, India – 400037
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Jinendra Qualipharm Private Limited
The main business activity of Jinendra Qualipharm is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Jinendra Qualipharm Private Limited FY 2025 filings available
Jinendra Qualipharm Private Limited reported revenue of ₹24.3 Cr (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Jinendra Qualipharm Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 219% over five years, including 32% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Jinendra Qualipharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16.89 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Jinendra Qualipharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 94.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 69.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jinendra Qualipharm are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Jinendra Qualipharm Private Limited
Jinendra Qualipharm has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Jain Also directs: Naulakha Impex LLP, Qualigens Pharma Private Limited | Director | 14 Jun 2022 | 4 Years 4 Months | Current |
| Anju Jain Also directs: Aawagaman Mercantile LLP, Vakunth Vinimay LLP, Ajaayu Trading and Consultancy Private Limited and 2 more | Director | 27 Jan 2015 | 11 Years 8 Months | Current |
| Drishti Ajit Jain Also directs: Ajaayu Trading and Consultancy Private Limited | Additional Director | 23 Dec 2024 | 1 Years 9 Months | Current |
| Tina Aayush Jain Also directs: Ajaayu Trading and Consultancy Private Limited | Additional Director | 23 Dec 2024 | 1 Years 9 Months | Current |
| Aayush Jain Also directs: Vakunth Vinimay LLP, Ajaayu Trading and Consultancy Private Limited, Evergrow Marketing Private Limited and 4 more | Director | 27 Jan 2015 | 11 Years 8 Months | Current |
Peer Comparison of Jinendra Qualipharm Private Limited
Jinendra Qualipharm Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunberg Life Sciences Private Limited | ₹24.43 Cr (FY 2025) | •••• | •••• | 92.0% | •••• | Chennai, Tamil Nadu, India |
| Axon Drugs Private Limited | ₹24.4 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Osaka Pharmaceuticals Private Limited | ₹24.38 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Vadodara, Gujarat, India |
| Kemecos India Pvt Ltd | ₹24.35 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Aeon Formulations Private Limited | ₹24.33 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Chennai, Tamil Nadu, India |
| Jinendra Qualipharm Private Limited this company | ₹24.3 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Mumbai, Maharashtra, India |
| Medior Healthcare Private Limited | ₹24.3 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Ahmedabad, Gujarat, India |
| Axacus Pharma Private Limited | ₹24.29 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Ahmedabad, Gujarat, India |
| Chemifine Formulations Private Limited | ₹24.25 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Nellore, Andhra Pradesh, India |
| Sunvij Drugs Private Limited | ₹24.23 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Vadodara, Gujarat, India |
| Auspik Pharmaceuticals Private Limited | ₹24.19 Cr (FY 2024) | •••• | •••• | 155.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Jinendra Qualipharm by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Jinendra Qualipharm Private Limited
Jinendra Qualipharm Private Limited is audited by Desai Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Desai Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Jinendra Qualipharm Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Jinendra Qualipharm Private Limited
Jinendra Qualipharm Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Jinendra Qualipharm Private Limited
Jinendra Qualipharm Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹55 Lakh; the latest was in March 2022.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Munirabad Trading Limited , Real Stone Exports Limited |
| Feb 2012 | Funding round | ₹40 Lakh | Investors: Real Stone Exports Limited, Munirabad Trading Limited |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Ajaayu Trading and Consultancy Private Limited Seller: Matrix Systel Private Limited |
| Feb 2010 | Funding round | ₹15 Lakh | Investors: Matrix Systel Private Limited |
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Jinendra Qualipharm Private Limited
Employment history and EPFO contributions of people linked to Jinendra Qualipharm.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Jinendra Qualipharm Private Limited
Jinendra Qualipharm Private Limited has 10 board changes on record since 2010: 5 appointments and 5 cessations. The latest: Drishti Ajit Jain was appointed as Additional Director on 23 Dec 2024.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Jinendra Qualipharm Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jinendra Qualipharm Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jinendra Qualipharm Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Jinendra Qualipharm Private Limited
Jinendra Qualipharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCJ2407R1Z9 | Maharashtra | Active | 15 Feb 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jinendra Qualipharm Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jinendra Qualipharm Private Limited
Jinendra Qualipharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 October 2009 (17+ years old) and is registered under CIN U24100MH2009PTC196480.
Jinendra Qualipharm reported revenue of ₹24.3 Cr for FY 2025 (up 32% YoY).
Jinendra Qualipharm has 5 current directors:
- Ajit Jain - Director
- Anju Jain - Director
- Drishti Ajit Jain - Additional Director
- Tina Aayush Jain - Additional Director
- Aayush Jain - Director
Jinendra Qualipharm reported a net profit of ₹16.89 Cr (net margin 69.5%) and EBITDA of ₹23 Cr (EBITDA margin 94.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Jinendra Qualipharm is 34% over three years and 219% over five years. In the latest year (FY 2025) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Jinendra Qualipharm is 27AACCJ2407R1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Jinendra Qualipharm is U24100MH2009PTC196480. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jinendra Qualipharm was incorporated on 15 October 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Jinendra Qualipharm has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹55 Lakh; the latest was in March 2022.
The peers of Jinendra Qualipharm by revenue are Sunberg Life Sciences Private Limited, Axon Drugs Private Limited, Osaka Pharmaceuticals Private Limited, Kemecos India Pvt Ltd, Aeon Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Drishti Ajit Jain was appointed as Additional Director on 23 Dec 2024. Tina Aayush Jain was appointed as Additional Director on 23 Dec 2024. Ajit Jain was appointed as Director on 14 Jun 2022. Jinendra Qualipharm has 10 board changes on record in total.